Author: rt

24 Oct NovioSense Announces Successful Clinical Trial and Secures 4th Round Financing for Its Tear Glucose Sensor with Noviotech as coinvestor

New US Investors and Harry G. Mitchell Join the NovioSense Team NIJMEGEN, Netherlands--October 24, 2016 Following successful clinical trials in 2015, NovioSense BV, today announced they had closed their 4th financing round for the next clinical validation phase of their smartphone based tear glucose sensor device, to...

Read More

22 Oct Novioscan launches noviomini at the MEDICA 2016 in Düsseldorf

Novioscan makes ultrasound technology wearable with its Noviomini solution Patients are increasingly empowered to take responsibility for their own health. Novioscan creates wearable ultrasound solutions for personalized health monitoring. Novioscan will launch its first product "Noviomini" at the MEDICA in Düsseldorf, from 14 - 17 November 2016, Hall...

Read More

09 Sep NovioMEMS presents at the IEEE International Ultrasonics Symposium

Optimization of piezo-MEMS layout for a bladder monitor Novioscans subsidiaries NovioMEMS and Novioscan Research present a poster at the 2016 edition of IEEE International Ultrasonics Symposium, TOURS, FRANCE, 18 to 21 September 2016. We combine analytic modeling, finite element simulations, and measurements to optimize the performance of four piezoelectric...

Read More

06 Sep NovioSense finanalist in the CODE_n CONTEST

NovioSense, CODE_n CONTEST Finalist in the HealthTech cluster, is a medical sensor company that develops cellphone-powered sensor devices for glucose monitoring in diabetics. Their first product is a non-invasive, wireless, cellphone-powered sensor that measures glucose levels in tears. CEO Dr. Christopher Wilson, gives his vision. Read for...

Read More

29 Apr Sensor Devices Inspired by the Five Senses: A Review

Publisher: Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim Authors from Noviosense BV, the Netherlands, and Grigore T. Popa University of Medicine and Pharmacy, Romania. Download Abstract Wearable devices (wearables) have recently gained significant traction and are predicted to dominate many areas of research over the next 5 years. Many...

Read More

14 Jul NovioTech participation NovioSense BV enters into a major patent portfolio agreement with Gentag, Mayo Clinic and Fraunhofer IMS

Gentag, Mayo Clinic, NovioSense and Fraunhofer Join Forces to Lower the Cost of Diabetes Care Globally WASHINGTON, ROCHESTER, Minn., NIJMEGEN, Netherlands and DUISBURG, Germany, July 14, 2015 /PRNewswire/ -- Exciting, new, patented technology platform poised to disrupt diabetes care delivery globally Extremely low-cost, pain-free system could be a game changer No...

Read More

13 Jul NovioMosae

NovioTech is pleased to announce the establishment of a sister company in the south of Limburg, the Netherlands, called NovioMosae BV. Noviomosae focuses on the development of IP and applications in close cooperation with local companies and knowledge centers. The CEO of NovioMosae is Françoise de Goeijen. Contact: Françoise...

Read More